Results 111 to 120 of about 4,641 (209)

Melarsoprol cyclodextrin inclusion complexes as promising oral candidates for the treatment of human African trypanosomiasis [PDF]

open access: yes, 2011
Human African trypanosomiasis (HAT), or sleeping sickness, results from infection with the protozoan parasites <i>Trypanosoma brucei</i> (<i>T.b.</i>) <i>gambiense</i> or <i>T.b.rhodesiense</i> and is ...
Jones, A.   +35 more
core   +1 more source

Naphthoquinone derivatives exert their antitrypanosomal activity via a multi-target mechanism [PDF]

open access: yes, 2013
Recently, we reported on a new class of naphthoquinone derivatives showing a promising anti-trypanosomatid profile in cell-based experiments. The lead of this series (B6, 2-phenoxy-1,4-naphthoquinone) showed an ED(50) of 80 nM against Trypanosoma brucei ...
Mazet Muriel   +82 more
core   +1 more source

Efficacy and safety of pafuramidine versus pentamidine maleate for treatment of first stage sleeping sickness in a randomized, comparator-controlled, international phase 3 clinical trial [PDF]

open access: yes, 2016
Sleeping sickness (human African trypanosomiasis [HAT]) is a neglected tropical disease with limited treatment options that currently require parenteral administration.
Carol A. Olson (1807531)   +71 more
core   +1 more source

Strategies for Trypanosoma brucei gambiense elimination [PDF]

open access: yesThe Lancet Global Health, 2017
Pandey, Abhishek, Galvani, Alison
openaire   +2 more sources

Enzyme variation in Trypanosoma brucei spp. I. Evidence for the sub-speciation of Trypanosoma brucei gambiense

open access: yesParasitology, 1984
SummaryThree groups of stocks of Trypanosoma brucei ssp, defined by the criteria of host, human serum resistance and place of isolation as T. b. gambiense, T. b. brucei (Nigeria) and T. b. brucei/rhodesiense (non-gambiense, Uganda) were screened for electrophoretic variation at 20 enzyme loci.
A, Tait, E A, Babiker, D, Le Ray
openaire   +2 more sources

Target product profile: <i>Trypanosoma brucei gambiense</i> test to verify elimination. [PDF]

open access: yesBull World Health Organ, 2023
Priotto G   +14 more
europepmc   +1 more source

Immunoinformatic design of a putative multi-epitope vaccine candidate against Trypanosoma brucei gambiense. [PDF]

open access: yesComput Struct Biotechnol J, 2022
Danazumi AU   +5 more
europepmc   +1 more source

A novel selection regime for differentiation defects demonstrates an essential role for the stumpy form in the life cycle of the African trypanosome [PDF]

open access: yes, 2000
A novel selection scheme has been developed to isolate bloodstream forms of Trypanosoma brucei, which are defective in their ability to differentiate to the procyclic stage.
Wilson, J   +4 more
core   +1 more source

Antigenic variation in African trypanosomes [PDF]

open access: yes, 2014
Studies on Variant Surface Glycoproteins (VSGs) and antigenic variation in the African trypanosome, Trypanosoma brucei, have yielded a remarkable range of novel and important insights. The features first identified in T.
Horn, David; id_orcid
core   +1 more source

Home - About - Disclaimer - Privacy